Tag: Liver Disease: Misc.
Childhood Adiposity Linked to Later Risk of Fatty Liver Disease
Likelihood of having NAFLD and ALT elevation can be mitigated by becoming nonobese in adulthood
High BMI in Late Teens Tied to Future Severe Liver Dz in Males
Development of T2DM further increases risk for severe liver disease, regardless of BMI
Caloric Restriction Normalizes Bile Acid, Cholesterol Deficiency
Hepatic BA, cholesterol deficient in morbid obesity; deficiencies counteracted by caloric restriction
Uric Acid Concentration, Fructose Intake Up NASH in Children
Independent associations seen in cohort of obese children with non-alcoholic fatty liver disease
hCG Reduces Caspase-3-Dependent IL-16 Expression
Absence of Caspase-3 activity results in reduction of processing and release of interleukin-16
Metformin Tied to Better Clinical Outcomes in CKD, CHF, CLD
Reduced all-cause death for chronic kidney disease, congestive heart failure, chronic liver disease
Addiction Consultation Valuable for Liver Transplant Patients
Increased alcohol consumption identified in interviews with addiction specialists vs hepatologists
Recommendations Developed for Pediatric NAFLD
Recommendations relate to screening, diagnosis, treatment, and long-term care of pediatric NAFLD
Bariatric Surgery Effective, Cost-Effective in Obese With NASH
For overweight patients, surgery is effective, but cost-effectiveness limited to those with F3 fibrosis
Optimal MELD Threshold for HCV Tx Pre-Liver Transplant 23 to 27
Treating HCV before liver transplant increased life expectancy if MELD was ≤27
